Trial Drug Shows Preliminary Promise Against Ovarian Cancer (HealthDay)

HealthDay - SUNDAY, Aug. 21 (HealthDay News) -- An experimental drug that's
shown promise against ovarian cancer caused by mutations in the BRCA1 or
BRCA2 genes may also be effective against ovarian cancer not caused by
those gene mutations, according to a new study.

Source: http://us.rd.yahoo.com/dailynews/rss/health/*http://news.yahoo.com/s/hsn/20110822/hl_hsn/trialdrugshowspreliminarypromiseagainstovariancancer

fitness exercise